EUVIMEDEUVIMED entdecken
Crossref

Bosutinib finds its place in the CML treatment paradigm

Michael Deininger

The Journal of Community and Supportive Oncology · 2013

DOI: 10.12788/j.cmonc.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2013. Verfasst von Michael Deininger.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Deininger, M. (2013). Bosutinib finds its place in the CML treatment paradigm. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.cmonc.0002

Vancouver

Deininger M. Bosutinib finds its place in the CML treatment paradigm. The Journal of Community and Supportive Oncology. 2013. doi:10.12788/j.cmonc.0002

BibTeX
@article{Deininger2013,
  author = {Deininger, Michael},
  title = {Bosutinib finds its place in the CML treatment paradigm},
  journal = {The Journal of Community and Supportive Oncology},
  year = {2013},
  doi = {10.12788/j.cmonc.0002}
}
Kostenlos starten →